| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.087 | 0.04 |